Baseline Characteristics and Interim Month 12 mNAPSI Results in Patients with Moderate-to- Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics in the Psoriasis Study of Health Outcomes (PSoHO)

被引：0
|
作者：
Egeberg, Alexander [1 ]
Pinter, Andreas [2 ]
Vender, Ronald [3 ]
Zaheri, Shirin [4 ]
Brnabic, Alan [5 ]
Schuster, Christopher [5 ,6 ]
Elrayes, Mohamed [5 ]
Reed, Catherine [5 ]
Riedl, Elisabeth [6 ]
Puig, Luis [7 ]
机构：
[1] Copenhagen Univ Hosp, Dept Dermatol, Copenhagen, Denmark
[2] Univ Hosp Frankfurt, Clin Dermatol Venereol & Allergol, Frankfurt, Germany
[3] Dermatrials Res Inc, Hamilton, ON, Canada
[4] HCA Healthcare, London, England
[5] Eli Lilly & Co, Indianapolis, IN USA
[6] Med Univ Vienna, Dept Dermatol, Vienna, Austria
[7] Univ Autonoma Barcelona, Dept Dermatol, IIB SANT PAU, Hosp Santa Creu & Sant Pau, Barcelona, Spain
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
42592
引用
下载
收藏
页码：AB127 / AB127
页数：1
相关论文
共 50 条
  • [21] Effectiveness of biologics in clinical practice in Australian patients: Week 12 primary outcomes from the international observational psoriasis study of health outcomes (PSoHO)
    Smith, Saxon D.
    Newson, Rachel
    Brnabic, Alan
    Hanna, Sylvia
    Mahar, Patrick
    Foley, Peter
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 16 - 17
  • [22] Effectiveness of Biologics in Clinical Practice in German patients: Week 12 Primary Outcomes from the International Observational Psoriasis Study of Health Outcomes (PSoHo)
    Schwarz, Beate
    Effendy, Isaak
    Kors, Christian
    Fotiou, Konstantinos
    Festini, Teodora
    Spina, Lara
    Machacek, Christian
    Pinter, Andreas
    Thaci, Diamant
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 64 - 64
  • [23] Baseline characteristics of patients with moderate to severe plaque psoriasis: post-hoc analysis of response to etanercept
    Gisondi, Paolo
    Girolomoni, Giampiero
    de Vlam, Kurt
    Al Hammadi, Anwar
    Carneiro, Sueli
    Arenberger, Petr
    Gallo, Gaia
    Jones, Heather
    Hsu, Ming-Ann
    Ferdousi, Tahmina
    Szumski, Annette
    Chhabra, Amit
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S26 - S26
  • [24] Bimekizumab versus secukinumab for the treatment of nail psoriasis in patients with moderate to severe plaque psoriasis: Results from the BE RADIANT phase 3b trial
    Eyerich, Kilian
    Gottlieb, Alice B.
    Piaserico, Stefano
    Beissert, Stefan
    Gooderham, Melinda
    Kirby, Brian
    Tilt, Nicola
    Madden, Cynthia
    Wiegratz, Susanne
    de Cuyper, Dirk
    Elewski, Boni
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB22 - AB22
  • [25] Bimekizumab versus Secukinumab for the Treatment of Nail Psoriasis in Patients with Moderate to Severe Plaque Psoriasis: Results from the BE RADIANT Phase 3b Trial
    Eyerich, Kilian
    Gottlieb, Alice B.
    Piaserico, Stefano
    Beissert, Stefan
    Gooderham, Melinda
    Kirby, Brian
    Tilt, Nicola
    Madden, Cynthia
    Wiegratz, Susanne
    de Cuyper, Dirk
    Merola, Joseph F.
    Elewski, Boni
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4467 - 4469
  • [26] A prospective noninterventional study to evaluate the psychosocial impact of biological treatment outcomes in patients with moderate-to-severe plaque psoriasis in the UK: interim results
    Bewley, Anthony
    Shafi, Mehbub
    Gorecki, Patricia
    Andiappan, Manoharan
    Kleyn, C. Elise
    Hunter, Hamish J. A.
    Shams, Kave
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 224 - 225
  • [27] Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational psoriasis study of health outcomes (PSoHO)
    Pinter, Andreas
    Puig, Luis
    Schaekel, Knut
    Reich, Adam
    Zaheri, Shirin
    Costanzo, Antonio
    Tsai, Tsen Fang
    Smith, Saxon D.
    Lynde, Charles
    Brnabic, Alan
    Reed, Catherine
    Hill, Julie
    Schuster, Christopher
    Riedl, Elisabeth
    Paul, Carle
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (11) : 2087 - 2100
  • [28] Certolizumab Pegol in Japanese Patients with Moderate to Severe Plaque Psoriasis: Effect of Demographics and Baseline Disease Characteristics on Efficacy
    Imafuku, Shinichi
    Tada, Yayoi
    Umezawa, Yoshinori
    Sakurai, Shinya
    Hoshii, Naoki
    Nakagawa, Hidemi
    DERMATOLOGY AND THERAPY, 2022, 12 (01) : 121 - 135
  • [29] Certolizumab Pegol in Japanese Patients with Moderate to Severe Plaque Psoriasis: Effect of Demographics and Baseline Disease Characteristics on Efficacy
    Shinichi Imafuku
    Yayoi Tada
    Yoshinori Umezawa
    Shinya Sakurai
    Naoki Hoshii
    Hidemi Nakagawa
    Dermatology and Therapy, 2022, 12 : 121 - 135
  • [30] Comparative Effectiveness of Biologic Classes in Clinical Practice: Month 12 Outcomes from the International Observational Psoriasis Study of Health Outcomes (PSoHO)
    Saakshi Khattri
    Álvaro González-Cantero
    Burhan Engin
    Sunil Dogra
    Caroline A. Murphy
    Christopher Schuster
    Naoto Tsujimoto
    Georgia Martimianaki
    Anastasia Lampropoulou
    Aya Alsharafi
    Bruce Konicek
    Felix Lauffer
    Advances in Therapy, 2025, 42 (1) : 233 - 245
12345